• Previsions show a CAGR of 6.9% for the biotech market in Healthcare reaching the 25% of global market for prescription drugs; industrial biotech is expected to increase to €228bn and the agricultural biotechnology market is expected reach a value of $12bn

  • Such promising figures require capacities to accelerate the entrance of new products into market

Who we are?

We are a biotechnology customer-centric company with strong background, providing solutions in health and food sectors:

  • We provide services helping our clients with a high level of flexibility, cost oriented, open communication, reliability and confidentiality

  • But we can also provide products thanks to our own antigen display technology with a strong potential to boost and direct specific immune responses, humoral or cellular depending on the construct

BDI Group - Biotechnology Development for industry

Business Lines

BDI Health

Services

Product development using different platforms

Process development

Scale up, industrialization

Contract Manufacturing

Products

Vaccine in animal health

Human health products

BDI Health - Biotechnology Development for industry

BDI Food

Services

Process development

Scale up, industrialization

Contract Manufacturing

BDI Food - Biotechnology Development for industry
BDI - Biotechnology Development for industry
BDI - Biotechnology Development for industry
BDI - Biotechnology Development for industry
Biotechnology

Investors

BDI SL is a privately held company supported by private investors.
BDI has also received public funds and financial support from the following entities:

We offer customized solutions contact us to discuss your project